Literature DB >> 21838184

N-terminal pro B-type natriuretic peptide levels in infants and children with acute non-cardiac diseases.

Inbar Nevo1, Mati Erlichman, Nurit Algur, Amiram Nir.   

Abstract

BACKGROUND: Cardiac patients express elevated levels of B-type natriuretic peptide and the amino terminal segment of its prohormone (NT-proBNP). However, there are non-cardiac causes of NT-proBNP level elevation.
OBJECTIVES: To determine the upper limit of NT-proBNP for pediatric patients with acute non-cardiac disease.
METHODS: We compared NT-proBNP concentrations in children with acute non-cardiac, mostly febrile disease with concentrations in children with acute cardiac disease and in healthy children. We used the Student t-test and Mann-Whitney test for group comparisons, and Pearson's and Spearman's correlation coefficients to test relationships between variables.
RESULTS: In 138 patients with acute non-cardiac diseases (mean age 3.7 years, 53% male), median NT-proBNP concentration was 162 pg/ml, upper limit (95% percentile) 1049 pg/ml. The level did not vary significantly by disease category; was negatively correlated with weight, weight percentile, age and hemoglobin level; and positively correlated with creatinine level. Multivariant analysis showed weight to be the only factor influencing NT-proBNP level. Levels were higher in children with acute non-cardiac diseases versus healthy children (median 88 pg/ml, P < 0.001, n = 59), and lower than levels in patients with acute cardiac disease (median 29,986 pg/ml, P < 0.001, n=30). Receiver operating characteristic analysis showed good NT-proBNP performance for differentiation between children with acute cardiac versus non-cardiac disease (area under the curve 0.958), at a cutoff of 415 pg/ml.
CONCLUSIONS: NT-proBNP levels are higher in children with acute non-cardiac diseases than in healthy children, but lower than in children with acute cardiac disease. NT-proBNP negatively correlated with weight and weight percentile.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21838184

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  6 in total

1.  Usefulness of amino terminal pro-B-type natriuretic peptide in evaluating children with cardiac failure.

Authors:  Isoken A Isah; Wilson E Sadoh; Nosakhare J Iduoriyekemwen
Journal:  Cardiovasc Diagn Ther       Date:  2017-08

2.  Copeptin as a serum biomarker of febrile seizures.

Authors:  Benjamin Stöcklin; Sotirios Fouzas; Paula Schillinger; Sevgi Cayir; Roswitha Skendaj; Michel Ramser; Peter Weber; Sven Wellmann
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

3.  Usefulness of Age-Stratified N-Terminal Prohormone of Brain Natriuretic Peptide for Diagnosing Kawasaki Disease.

Authors:  Sang Hoon Lee; Eun Song Song; Somy Yoon; Seunghee Hong; Hwa Jin Cho; Eun Mi Yang; Gwang Hyeon Eom; Gaeun Kang; Young Kuk Cho
Journal:  Dis Markers       Date:  2017-11-22       Impact factor: 3.434

Review 4.  Circulating Circular RNAs: Novel Biomarkers for Heart Failure.

Authors:  Chuan Sun; Mingming Ni; Bo Song; Lu Cao
Journal:  Front Pharmacol       Date:  2020-11-13       Impact factor: 5.810

5.  Serum NT-Pro-BNP versus Noninvasive Bedside Inotropic Index in Paediatric Shock: A Contest of Myocardial Performance in Response to Fluid Loading.

Authors:  Antonius Hocky Pudjiadi; Tuty Rahayu; Stephanie Wijaya; Fatima Safira Alatas
Journal:  Crit Care Res Pract       Date:  2021-11-30

6.  Predictive value of cardiac markers in the prognosis of COVID-19 in children.

Authors:  Ufuk Utku Güllü; Şükrü Güngör; Sevcan İpek; Sadık Yurttutan; Cengiz Dilber
Journal:  Am J Emerg Med       Date:  2021-07-06       Impact factor: 2.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.